Sido Muncul Poised for Renewed Growth on Strong Herbal and Beverage Sales Momentum
Key Takeaways
|
JAKARTA, Investortrust.id — Herbal-medicine producer PT Industri Jamu dan Farmasi Sido Muncul Tbk, or SIDO, continues to demonstrate operational resilience, with its third-quarter 2025 results showing double-digit growth in key segments and sustaining one of the strongest profit margins in Indonesia’s consumer-staples sector.
The company’s share price closed at Rp 560 on Friday, Oct 31, 2025, but InvestingPro’s fair-value models place SIDO’s intrinsic value at Rp 695.35, implying a potential upside of 24.2%. Market analysts also expect further momentum ahead of the company’s next earnings announcement on Nov 3.
Strong Herbal and Beverage Growth
According to a report by PT Indo Premier Sekuritas (IPOT), Sido Muncul booked Rp 900 billion in revenue in Q3 2025, up 23.3% year-on-year, driven by its herbal and food-and-beverage (F&B) divisions, which grew 22% and 27.3%, respectively.
“Herbal remains the backbone of Sido Muncul’s profitability, but the faster expansion of beverages shows the company’s successful diversification strategy,” wrote Indo Premier analysts Andrianto Saputra and Nicholas Bryan in their Oct 31 report.
The analysts noted that improved sales through general and modern-trade channels—particularly third-party distributors whose sales surged 95.6% yoy—signal a healthy rebound in domestic demand after a slow start earlier in the year.
Margins Hold Firm Despite Higher Expenses
The company’s gross profit margin (GPM) strengthened to 56.2%, gaining 360 basis points from a year earlier, largely supported by a 774 bps improvement in F&B margins and favorable product mix.
While operating expenses rose 41% yoy as marketing and advertising spending increased, Sido Muncul still achieved a net profit of Rp 218 billion, up 28.6% yoy, with a net margin of 24.2%.
For the first nine months of 2025, the company recorded Rp 819 billion in net profit (+5.2% yoy) and Rp 2.7 trillion in revenue (+3.9% yoy), in line with management’s full-year guidance for growth above 5%.
Disclaimer: All data and valuations referenced herein are provided by InvestingPro as of Oct 31, 2025, based on publicly available financial statements and analyst consensus. InvestingPro’s fair-value estimates represent median outputs of quantitative valuation models and are not guarantees of future performance.
Valuation: Room for Re-rating Ahead
Despite the near-term HOLD call from Indo Premier, which maintained a target price of Rp 625 based on 15.0× FY2025 forward P/E, the broader valuation picture points to latent upside.
At Rp 560 per share, SIDO trades at only 13.9× 12-month forward earnings, roughly 1.2 standard deviations below its five-year average. This suggests that the market continues to underprice the company’s earnings consistency and cash-flow quality.
By comparison, regional peers in the consumer-staples sector trade at 15–17× forward earnings, with similar or lower dividend yields. SIDO’s return on equity (ROE) remains among the highest in its category, at 35.1% in 2025F, supported by a net margin of 29.7% and a zero-debt balance sheet.
Investors also benefit from a dividend yield of around 6.4%, which Indo Premier expects to be sustained in coming years. Combined with potential multiple expansion as domestic purchasing power improves in 2026, the total return opportunity could exceed 25% from current levels.
InvestingPro’s valuation models, derived from 15 independent models, estimate Sido Muncul’s fair-value range between Rp 454 and Rp 998, reinforcing the stock’s medium-risk, high-quality profile.
In other words, even under conservative scenarios, Sido Muncul’s strong balance sheet and high-margin herbal portfolio provide substantial downside protection—making the stock attractive for investors seeking stability with dividend income and moderate growth exposure.